Skip to Main Content

Paper Details

The cholesterol-lowering effect of statins is modified by <i>LILRB5</i> intolerance genotype: Results from a recruit-by-genotype clinical trial.
Front Pharmacol
0
2023
Asp247Asp, Asp247Gly, CK, Gly247Gly, Participants, Statin, T regulatory cell, T regulatory cells, atorvastatin, cholesterol, creatine, creatine kinase, intolerance, non-HDL cholesterol, participants, statin, statin intolerance, statin-induced myalgia, statins
Author NameAffiliation
Moneeza K SiddiquiPat Macpherson Centre for Pharmacogenomics and Pharmacogenetics, University of Dundee
Daniel I ChasmanBrigham and Women's Hospital, Harvard Medical School
Daniel I ChasmanBrigham and Women's Hospital, Harvard Medical School
Alex S F DoneyPat Macpherson Centre for Pharmacogenomics and Pharmacogenetics, University of Dundee
Alex S F DoneyPat Macpherson Centre for Pharmacogenomics and Pharmacogenetics, University of Dundee
Colin N A PalmerPat Macpherson Centre for Pharmacogenomics and Pharmacogenetics, University of Dundee
Colin N A PalmerPat Macpherson Centre for Pharmacogenomics and Pharmacogenetics, University of Dundee
  • 1 - 7

Datasets

Release 1.2